John Gorman currently serves as the Senior Director of Market Access at Indivior, where he leverages his extensive expertise in the pharmaceutical industry to drive innovative solutions for complex healthcare challenges. With a specialized focus on the New York State Criminal Justice Systems, John is...
John Gorman currently serves as the Senior Director of Market Access at Indivior, where he leverages his extensive expertise in the pharmaceutical industry to drive innovative solutions for complex healthcare challenges. With a specialized focus on the New York State Criminal Justice Systems, John is dedicated to improving treatment accessibility for individuals grappling with Opioid Use Disorder and Severe Mental Illness. His role involves strategic collaboration with various stakeholders, including healthcare providers, policymakers, and community organizations, to ensure that effective therapies are available to those who need them most.
John's comprehensive background spans multiple therapeutic areas, including Schizophrenia, Cardiovascular health, Diabetes, and Infectious Diseases, which equips him with a holistic understanding of patient needs and market dynamics. His proficiency in pharmaceutical sales and market access strategies enables him to navigate the complexities of healthcare reimbursement and regulatory landscapes, ensuring that Indivior's groundbreaking treatments reach the patients who require them.
Key projects under John's leadership include initiatives aimed at enhancing treatment pathways for vulnerable populations, particularly within the criminal justice system. By fostering cross-functional team leadership and engaging in collaborative efforts, he is committed to addressing the stigma surrounding mental health and substance use disorders. John's passion for improving patient outcomes, combined with his strategic vision and industry knowledge, positions him as a pivotal figure in advancing Indivior's mission to transform lives through innovative healthcare solutions.
